Tecan Group AG

SW:TECN Switzerland Medical Instruments & Supplies
Market Cap
$1.63 Billion
CHF1.49 Billion CHF
Market Cap Rank
#5564 Global
#32 in Switzerland
Share Price
CHF117.40
Change (1 day)
-3.37%
52-Week Range
CHF117.40 - CHF179.60
All Time High
CHF586.60
Categories
Companies in Switzerland Medical Instruments & Supplies
About

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, … Read more

Tecan Group AG (TECN) - Net Assets

Latest net assets as of June 2025: CHF1.28 Billion CHF

Based on the latest financial reports, Tecan Group AG (TECN) has net assets worth CHF1.28 Billion CHF as of June 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CHF1.94 Billion) and total liabilities (CHF656.74 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets CHF1.28 Billion
% of Total Assets 66.12%
Annual Growth Rate 10.48%
5-Year Change 91.36%
10-Year Change 225.71%
Growth Volatility 20.41

Tecan Group AG - Net Assets Trend (2002–2024)

This chart illustrates how Tecan Group AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Tecan Group AG (2002–2024)

The table below shows the annual net assets of Tecan Group AG from 2002 to 2024.

Year Net Assets Change
2024-12-31 CHF1.44 Billion +6.41%
2023-12-31 CHF1.35 Billion -2.53%
2022-12-31 CHF1.38 Billion +11.28%
2021-12-31 CHF1.24 Billion +65.80%
2020-12-31 CHF750.06 Million +13.81%
2019-12-31 CHF659.07 Million +7.62%
2018-12-31 CHF612.41 Million +11.32%
2017-12-31 CHF550.12 Million +12.94%
2016-12-31 CHF487.08 Million +10.53%
2015-12-31 CHF440.67 Million +22.00%
2014-12-31 CHF361.20 Million +7.43%
2013-12-31 CHF336.20 Million +11.02%
2012-12-31 CHF302.84 Million +12.45%
2011-12-31 CHF269.31 Million +18.10%
2010-12-31 CHF228.04 Million +12.37%
2009-12-31 CHF202.93 Million +27.48%
2008-12-31 CHF159.19 Million -22.21%
2007-12-31 CHF204.64 Million +11.32%
2006-12-31 CHF183.84 Million +28.26%
2005-12-31 CHF143.33 Million +52.07%
2004-12-31 CHF94.26 Million -14.79%
2003-12-31 CHF110.62 Million -30.96%
2002-12-31 CHF160.22 Million --

Equity Component Analysis

This analysis shows how different components contribute to Tecan Group AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 485.6% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings CHF1.11 Billion 77.46%
Common Stock CHF1.28 Million 0.09%
Other Comprehensive Income CHF351.17 Million 24.47%
Total Equity CHF1.44 Billion 100.00%

Tecan Group AG Competitors by Market Cap

The table below lists competitors of Tecan Group AG ranked by their market capitalization.

Company Market Cap
Dialog Group Bhd
KLSE:7277
 		$1.62 Billion
Yantai Moon Co Ltd
SHE:000811
 		$1.62 Billion
Foxconn Technology Co. Ltd.
OTCGREY:FXCOF
 		$1.62 Billion
Turning Point Brands Inc
NYSE:TPB
 		$1.63 Billion
Optima bank SA
AT:OPTIMA
 		$1.62 Billion
Shihlin Electric & Engineering Corp
TW:1503
 		$1.62 Billion
Petronas Dagangan Bhd
KLSE:5681
 		$1.62 Billion
Hanjinkal
KO:180640
 		$1.62 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Tecan Group AG's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 1,348,910,000 to 1,435,331,000, a change of 86,421,000 (6.4%).
  • Net income of 67,664,000 contributed positively to equity growth.
  • Dividend payments of 38,320,000 reduced retained earnings.
  • Share repurchases of 28,934,000 reduced equity.
  • New share issuances of 1,358,000 increased equity.
  • Other comprehensive income increased equity by 71,158,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income CHF67.66 Million +4.71%
Dividends Paid CHF38.32 Million -2.67%
Share Repurchases CHF28.93 Million -2.02%
Share Issuances CHF1.36 Million +0.09%
Other Comprehensive Income CHF71.16 Million +4.96%
Other Changes CHF13.49 Million +0.94%
Total Change CHF- 6.41%

Book Value vs Market Value Analysis

This analysis compares Tecan Group AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.05x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 9.35x to 1.05x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2002-12-31 CHF12.56 CHF117.40 x
2003-12-31 CHF9.49 CHF117.40 x
2004-12-31 CHF8.59 CHF117.40 x
2005-12-31 CHF12.97 CHF117.40 x
2006-12-31 CHF15.90 CHF117.40 x
2007-12-31 CHF17.66 CHF117.40 x
2008-12-31 CHF14.57 CHF117.40 x
2009-12-31 CHF19.54 CHF117.40 x
2010-12-31 CHF21.54 CHF117.40 x
2011-12-31 CHF24.67 CHF117.40 x
2012-12-31 CHF27.61 CHF117.40 x
2013-12-31 CHF30.22 CHF117.40 x
2014-12-31 CHF32.08 CHF117.40 x
2015-12-31 CHF38.21 CHF117.40 x
2016-12-31 CHF41.63 CHF117.40 x
2017-12-31 CHF46.61 CHF117.40 x
2018-12-31 CHF51.59 CHF117.40 x
2019-12-31 CHF55.22 CHF117.40 x
2020-12-31 CHF60.98 CHF117.40 x
2021-12-31 CHF99.43 CHF117.40 x
2022-12-31 CHF106.17 CHF117.40 x
2023-12-31 CHF105.21 CHF117.40 x
2024-12-31 CHF112.30 CHF117.40 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Tecan Group AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 4.71%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 7.24%
  • • Asset Turnover: 0.44x
  • • Equity Multiplier: 1.48x
  • Recent ROE (4.71%) is below the historical average (13.67%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2002 20.58% 9.93% 1.45x 1.43x CHF16.95 Million
2003 12.73% 4.52% 1.39x 2.03x CHF3.02 Million
2004 13.50% 4.45% 1.49x 2.03x CHF3.30 Million
2005 9.74% 4.05% 1.02x 2.36x CHF-379.30K
2006 22.11% 10.01% 1.11x 1.99x CHF22.25 Million
2007 25.60% 12.64% 1.11x 1.83x CHF31.91 Million
2008 16.10% 6.47% 1.22x 2.05x CHF9.70 Million
2009 24.31% 12.59% 1.12x 1.72x CHF29.05 Million
2010 7.11% 4.37% 1.09x 1.48x CHF-6.60 Million
2011 17.66% 12.62% 0.97x 1.45x CHF20.63 Million
2012 13.92% 10.78% 0.93x 1.39x CHF11.87 Million
2013 13.58% 11.76% 0.83x 1.39x CHF12.05 Million
2014 11.13% 10.07% 0.72x 1.53x CHF4.10 Million
2015 12.97% 12.98% 0.69x 1.46x CHF13.08 Million
2016 11.20% 10.77% 0.69x 1.51x CHF5.83 Million
2017 12.10% 12.13% 0.68x 1.46x CHF11.53 Million
2018 11.54% 11.91% 0.69x 1.40x CHF9.46 Million
2019 11.10% 11.49% 0.68x 1.43x CHF7.26 Million
2020 14.13% 14.19% 0.65x 1.54x CHF30.32 Million
2021 9.93% 12.85% 0.46x 1.67x CHF-830.50K
2022 8.92% 10.59% 0.53x 1.59x CHF-14.65 Million
2023 9.79% 12.29% 0.52x 1.54x CHF-2.82 Million
2024 4.71% 7.24% 0.44x 1.48x CHF-75.87 Million

Industry Comparison

This section compares Tecan Group AG's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

  • Industry: Medical Instruments & Supplies
  • Average net assets among peers: $117,275,500
  • Average return on equity (ROE) among peers: 9.42%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Tecan Group AG (TECN) CHF1.28 Billion 20.58% 0.51x $1.62 Billion
SKAN Group AG (SKAN) $82.55 Million 5.49% 2.14x $646.08 Million
IVF Hartmann Holding AG (VBSN) $152.00 Million 13.36% 0.24x $95.84 Million